2BBBullish & Bearish
Dermata Therapeutics, Inc. (DRMA) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 24 out of 100.
Dermata Therapeutics, Inc.’s current 2BB score is 24 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 48 | Stable |
| Financial strength | 11 | Very Weak |
| Quality | 20 | Weak |
| Risk | 49 | Moderate |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-12 | — | -0.6426 | — | $25,500.00 |
| 2026-08-11 | — | -0.561 | — | $0.00 |
| 2026-05-12 | — | -0.7344 | — | — |
| 2026-03-17 | — | -1.5708 | — | — |